Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
12.45 +0.48 (+4.01%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 12.45 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
11.94
Day High
12.56
Open 11.99
Previous Close 11.97 11.97
Volume 201,700 201,700
Avg Vol 262,835 262,835
Stochastic %K 32.29% 32.29%
Weighted Alpha +224.87 +224.87
5-Day Change +0.62 (+5.24%) +0.62 (+5.24%)
52-Week Range 3.03 - 18.41 3.03 - 18.41
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 333,884
  • Shares Outstanding, K 26,818
  • Annual Sales, $ 39,010 K
  • Annual Income, $ -3,820 K
  • EBIT $ -3 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.34
  • Price/Sales 8.23
  • Price/Cash Flow N/A
  • Price/Book 12.77

Options Overview Details

View History
  • Implied Volatility 105.99% ( -1.39%)
  • Historical Volatility 65.22%
  • IV Percentile 60%
  • IV Rank 21.63%
  • IV High 342.43% on 05/07/24
  • IV Low 40.73% on 10/07/24
  • Put/Call Vol Ratio 0.04
  • Today's Volume 26
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 1,420
  • Open Int (30-Day) 1,514

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.05
  • Number of Estimates 2
  • High Estimate 0.06
  • Low Estimate 0.04
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +266.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.09 +12.30%
on 04/07/25
Period Open: 14.10
15.73 -20.85%
on 03/17/25
-1.65 (-11.70%)
since 03/11/25
3-Month
11.09 +12.30%
on 04/07/25
Period Open: 13.44
18.41 -32.36%
on 02/05/25
-0.99 (-7.37%)
since 01/10/25
52-Week
3.03 +310.89%
on 04/17/24
Period Open: 3.44
18.41 -32.36%
on 02/05/25
+9.01 (+261.92%)
since 04/11/24

Most Recent Stories

More News
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

ETON : 12.45 (+4.01%)
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

ETON : 12.45 (+4.01%)
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

ETON : 12.45 (+4.01%)
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

ETON : 12.45 (+4.01%)
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

ETON : 12.45 (+4.01%)
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

ETON : 12.45 (+4.01%)
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

ETON : 12.45 (+4.01%)
New Strong Buy Stocks for January 28th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Potbelly Corporation PBPB: This franchise company has seen the Zacks Consensus Estimate for its current year earnings increasing...

PBPB : 8.24 (-2.60%)
BBCP : 5.76 (+1.59%)
NVAX : 5.86 (+7.92%)
BAK : 3.40 (+2.72%)
ETON : 12.45 (+4.01%)
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

ETON : 12.45 (+4.01%)
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

ETON : 12.45 (+4.01%)

Business Summary

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

See More

Key Turning Points

3rd Resistance Point 13.32
2nd Resistance Point 12.94
1st Resistance Point 12.69
Last Price 12.45
1st Support Level 12.07
2nd Support Level 11.69
3rd Support Level 11.44

See More

52-Week High 18.41
Fibonacci 61.8% 12.53
Last Price 12.45
Fibonacci 50% 10.72
Fibonacci 38.2% 8.90
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar